Caspase-3 deficiency during development increases vulnerability to hypoxic–ischemic injury through caspase-3-independent pathways

• Main Authors: Tim West, Madeliene Atzeva, David M. Holtzman
• Format: Article
• Language: English
• Published: Elsevier 2006-06-01
• Series: Neurobiology of Disease
• Subjects: Neonatal; Hypoxia–ischemia; Casapse-3; Apoptosis; Cell death; DNA laddering
• Online Access: http://www.sciencedirect.com/science/article/pii/S0969996105003487

Neonatal hypoxia–ischemia (H–I) is a common cause of perinatal morbidity and mortality leading to prominent activation of caspase-3 in the brain. Previous studies have shown that acute inhibition of caspase-3 can protect against neonatal H–I in rats. In this study, we investigated brain injury following neonatal H–I in mice deficient in caspase-3. Wild-type, caspase-3+/− and caspase-3−/− mice underwent unilateral carotid ligation at postnatal day (P) 7, followed by 45 min of exposure to 8% oxygen. Surprisingly, tissue loss at P14 was significantly higher in caspase-3−/− mice when compared to wild-type littermates. As in rats, we found that acute inhibition of caspase-3 in mice leads to decrease in tissue loss at P14. There was no difference in nuclear morphology, DNA laddering or calpain activation between caspase-3−/−, caspase-3+/− and wild-type mice subjected to H–I, and there was no evidence for compensatory activation of other caspases in caspase-3−/− mice. Also, all genotypes showed evidence of mitochondrial dysfunction after H–I, suggesting that this is a critical point in regulation of neuronal cell death following neonatal H–I. Our results suggest that long-term inhibition of caspase-3 during development, unlike acute inhibition, leads to upregulation of caspase-3-independent cell death pathways and increases the vulnerability of the developing brain to neonatal H–I injury.